Skip to Main Content

Paper Details

Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancer.
Am J Cancer Res
5
2022
Author NameAffiliation
Jeeyun LeeSamsung Medical Center, Sungkyunkwan University School of Medicine Seoul
  • 1 - 1

Datasets

Release 1.2